Meridian Wealth Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,895
Closed -$685K 226
2019
Q3
$685K Sell
6,895
-35
-0.5% -$3.33K 0.32% 60
2019
Q2
$6.41K Sell
6,930
-4,886
-41% -$464K 0.26% 61
2019
Q1
$1.11M Sell
11,816
-1,827
-13% -$160K 0.51% 38
2018
Q4
$874K Buy
13,643
+1,810
+15% +$134K 0.51% 43
2018
Q3
$1.06M Buy
11,833
+2,673
+29% +$236K 0.46% 40
2018
Q2
$727K Sell
9,160
-133
-1% -$11K 0.34% 54
2018
Q1
$829K Sell
9,293
-1,070
-10% -$103K 0.41% 48
2017
Q4
$1.49M Hold
10,363
0.92% 22
2017
Q3
$1.51M Buy
10,363
+2,967
+40% +$404K 0.96% 22
2017
Q2
$961K Buy
7,396
+1,125
+18% +$138K 0.61% 27
2017
Q1
$780K Buy
+6,271
New +$750K 0.47% 49

Other funds holding CELG

Meridian Wealth Management's CELG Position: Q4 2019 in Review

Meridian Wealth Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,895 shares — an estimated $685K sold.

Meridian Wealth Management first reported a position in CELG in Q1 2017 and held it in 11 quarters. The position peaked at $1.51M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Meridian Wealth Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Meridian Wealth Management sold 6,895 Celgene Corp shares in Q4 2019, an estimated $685K.
  • Meridian Wealth Management first reported a position in Celgene Corp in Q1 2017 and held it in 11 quarters.
  • Meridian Wealth Management's Celgene Corp position peaked at $1.51M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Meridian Wealth Management's 13F filing for Q4 2019, filed 9 Jan 2020.